RecruitingNot ApplicableNCT03868592

Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis


Sponsor

Mayo Clinic

Enrollment

30 participants

Start Date

Aug 1, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

It is not known how much improvement in insulin regulated lipolysis (the breakdown of triglycerides) occurs following substantial, sustained weight loss. Researchers will test the effects of inflammation and lipolysis regulation in people before and after bariatric surgery (sleeve gastrectomy) to answer these questions.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Gastric sleeve/bariatric surgery for people with obesity, morbid. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREGastric sleeve/bariatric surgery

weight loss


Locations(1)

Mayo Clinic

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03868592


Related Trials